The improvements include a new cat ward designed to offer a quieter, more relaxing area away from other animals, and a new walk-in dog ward which will allow staff to treat larger breeds of dogs more easily. The intensive care unit has been expanded and the practice has developed a new chemotherapy area.
John Turkington, the partner at Scarsdale Vets responsible for overseeing the work said: "We are already really proud of the state-of-the-art facilities we have at Pride, but we are not complacent and that is why we have made this significant investment to improve our facilities and ultimately the services we offer our clients and patients. Patient comfort is paramount, which is why we’ve invested in an additional walk in ward for our larger breeds, and a new cat ward with a separate feline examination and treatment area."
As well as the changes to improve clinical care, the practice has also invested in its kennelling services, increasing the number of 'suites' for cats and dogs to stay in its 'hotel' areas whilst their owners go on holiday.
John added: "We want Pride to be recognised as one of the best veterinary hospitals in Europe and to make that a reality we have increased our ward capacity for patient comfort and clinical treatment areas, as well as improving facilities behind the scenes for our staff, to create a better working environment. Alongside that the improvements to our Pet Resort will also meet the growing demands from clients for those services."
Dr Pete Down, Associate Dean for Undergraduate Education in UCLan’s School of Veterinary Medicine, said: “We recognise the multifaceted challenges the profession is facing at the moment, but many of us have spent significant time out in practice and recognise that it can be a fantastic career.
“Additionally, first-opinion vets provide essential services to the pet-owning public, equine, and farming industries.
"Our curriculum focusses on the provision of contextual-care and encourages vet students to see general practice as a fantastic career in and of itself.
"Also, whilst diversity in the profession has traditionally been a challenge, our student recruitment practices support an inclusive approach, recruiting students from a wide variety of backgrounds.”
The practically focused curriculum is ‘hands-on’ from year one and the university says it uses innovative digital technologies from the outset: its students will be among the first in the country to use specialist Anatomage vet tables.
Dr Heather Bacon OBE, Dean of UCLan’s School of Veterinary Medicine, said: “It’s a landmark day for the University as we’ve welcomed our first cohort of veterinary medicine students through the door.
"The demand for places on the first year of our BVMS course was huge and I’m thrilled we’ve been able to enrol so many enthusiastic student vets on to our programme.”
https://www.uclan.ac.uk/undergraduate/courses/veterinary-medicine-surgery-bvms
Fort Dodge has released figures today which point to a continued modest slowdown in the UK veterinary sector, being mitigated by a slight increase in average transaction value (the amount a client spends in a year).
Matthew Rowe, Companion Animal Marketing Manager at Fort Dodge, said: "It's been clear for some time that the veterinary sector is being hit by static growth and an increasingly competitive environment. The reduction in turnover being experienced by many practices is primarily down to current clients visiting less often and fewer new clients being attracted."
Key findings of the Fort Dodge Index for the first quarter of 2009 are:
Alan Robinson said: "In the current climate, the only contributor to turnover growth in many practices seems to be a steady rise in the price of professional fees, consultations and surgery. These have continued to push up average transaction values (by 1.4%) and client values (1.2%) in this first quarter of 2009 despite reducing visit frequency. Drug related income increases seem to be driven by a small increase of POM mark-ups in many practices.
"But this alone will not sustain a successful business and, with transaction volumes still falling, the priority for practices is to maintain client footfall despite increasing competition and falling pet ownership. In today's market, retaining clients is a cheaper and more effective way to maintain client and patient numbers so an emphasis on 'bonding' clients though preventative health care and heath maintenance programmes is key.
"We're seeing a steady increase in the number of practices running these programmes but the percentage of pets involved is still woefully low so the message is that practices can and must do better.
The Blue Cross is calling for nominations from veterinary practices across the country for its Veterinary Nurse of the Year Award 2010.
The annual award is presented at the British Veterinary Nursing Association (BVNA) Annual Congress in October. It recognises the contribution of veterinary nurses in educating the public about responsible pet ownership and the welfare of pets in the community.
Last year's award was won by Vania Brasseleur for her outstanding contribution to animal welfare, both within her veterinary practice and among the local community in Newport Pagnell, Buckinghamshire
Vania was nominated for the award by student vet nurse and colleague Emily Martin at Astonlee Veterinary Hospital in Newport Pagnell.
Emily said: "Vania is committed to helping student nurses broaden their knowledge and help them on to the path to qualification. Her charity work, serving the public, helping colleagues and of course her nursing abilities are all truly fantastic! I don't think anybody could ask for a better nurse."
Nominations for this year's award can be made by completing the nomination form on The Blue Cross website at: www.bluecross.org.uk/BVNA2010 or by contacting Sally Leathem on 01993 825577. The deadline for nominations is Friday 20 August 2010.
The competition is open to all UK-based undergraduate veterinary students and offers them the opportunity to work as a team to brainstorm, develop and present an innovative idea to a board of industry professionals.
Students can enter either as a single applicant or as a group (of roughly five members), with single applicants then being placed in a group with other applicants from their university. There can be more than one team representing each university.
Each student’s project can cover any aspect of veterinary health innovation. The RCVS suggests potential projects might include: innovations within veterinary education, innovations to improve sanitation and hygiene, innovations to improve veterinary-public communication and innovations to improve patient safety.
Entries must show how they have improved upon – or extended beyond – current expectations of best practice in their chosen area.
Each applicant will receive support from one of the Association of Veterinary Students’ (AVS) Vet Futures Ambassadors, as well as a mentor session with a chosen industry professional to guide them on their project.
Teams will need to submit three components for judging: a log of their progress throughout the project (which can include social media updates using the hashtag #ViVetStudentInnovation), mentor engagement and feedback, and a five-minute video ‘business pitch’.
The three finalist groups of the competition will be invited to present their pitch to a board of industry professionals at a ‘Dragon’s Den’ style event held at the RCVS ViVet 2019 Innovation Symposium on Tuesday 1 October 2019 in Manchester.
The winning and runner-up groups will then be selected and will be presented alongside the ‘mentor’s choice’ award. The Mentor’s Choice award will be selected by the team mentors. The prize will be awarded to an individual who shows excellence and enthusiasm within their work on the project.
Anthony Roberts, RCVS Director of Leadership & Innovation (pictured right), said: "This competition provides a great opportunity for veterinary students to engage with their fellow classmates across different fields of study and to work on projects that could genuinely make a difference to animal health and welfare and the way veterinary services are delivered. Teams will receive one-on-one mentoring and will be guided through the innovation process, developing skills that will be useful throughout their careers. We look forward to seeing the three finalist teams presenting at the RCVS ViVet Innovation Symposium in Manchester on 1 October."
Zoe Skinner, Vet Futures Student Representatives Team Leader, said: “This competition is a great opportunity for veterinary students to receive mentoring from experienced veterinary professionals and form contacts within our profession. It gives students a way to work together as a team and allows them to learn how to produce and develop innovative, problem-solving concepts as well as skills in delivering presentations. These are all important aspects of our career ahead, which will look brilliant on our CV’s.”
ViVet is now accepting registrations for the competition for the 2018/19 academic year. To enter, applicants must submit an online registration form. For further information, email info@vivet.org.uk.
The organisations made a joint submission to the Migration Advisory Committee (MAC) as part of its review into the Shortage Occupation List which began in autumn 2018 and will report back in spring 2019.
The BVA and the RCVS had previously made calls for the profession to be added to the list in 2017 when the MAC held a call for evidence on the impact of the UK's exit from the EU on various professions. The latest submission is a development on this previous submission, focused on the need for the post-Brexit immigration system to recognise the issues affecting the veterinary workforce, which is already under-capacity, and reiterating its importance in areas such as public health, food safety, disease surveillance and control, education, research, clinical practice and animal welfare.
The submission details how the demand for veterinary services does not currently match supply and that the UK is therefore reliant on overseas registrants, particularly from the rest of the EU, who currently make up around 50% of new registrants in a given year.
The RCVS and BVA add that, in the post-Brexit immigration system, this reliance on overseas vets needs to be recognised by adding veterinary surgeons to the Shortage Occupation List, thus reducing the immigration requirements needed for overseas veterinary surgeons to live and work in the UK and streamlining the application process for employers.
Amanda Boag, RCVS President, said: "We wanted to use this submission as an opportunity to reiterate the circumstances currently facing the profession, particularly in light of the uncertainties around the UK’s exit from the EU and the impact this could have on the supply of veterinary workforce from the rest of the EU, which is crucially important in a number of areas. We need, therefore, for veterinary surgeons to be immediately added back to the list so that we can ensure that this flow of workforce continues and that animal health and welfare is protected.
"In the meantime we are continuing to work with BVA and the Department for Environment, Food and Rural Affairs (Defra) to look at how we can develop ‘home-grown’ veterinary capacity in the UK through expanding the UK veterinary education sector, increasing retention rates within the profession, and looking at how the veterinary team could be reformed to allow allied professionals, such as veterinary nurses, to take on extra tasks and free up veterinary time. However, these are all long-term projects and not quick fixes to the issues facing the profession."
As well as calling for a future immigration system to prioritise the veterinary profession, RCVS and BVA also recommend that veterinary employers be exempt from the Immigration Skills Charge to avoid additional barriers or burdens to the employment of overseas vets and recommend that there is no minimum earning cap for veterinary surgeons applying for work visas, on the basis that veterinary surgeons are "skilled professionals who may choose to work in the UK for reasons other than remuneration".
Simon Doherty, BVA President, said: "It is in MAC’s gift to reinstate vets on the Shortage Occupation List and this evidence makes a strong case for it to happen as quickly as possible.
"Vets deliver multiple benefits to animal health and welfare, public health and food safety, and they have a crucial role to play in future trade deals and keeping standards and confidence in UK exports high. The profession is also indebted to a high proportion of skilled EU vets who have chosen to make the UK their home and place of work.
"With this in mind, the future immigration system must be geared around preserving veterinary capacity rather than introducing new layers of bureaucracy or restrictions on flexible movement between roles. We have raised concerns that extending the Immigration Skills Charge to EU workers would hit some areas of the workforce disproportionately hard, particularly the abattoir industry where 95 per cent of Official Veterinarians hail from overseas.
"With uncertain times ahead and demand for some veterinary services predicted to spiral after Brexit, it has never been more pressing to take decisive action to safeguard against shortfalls in capacity and give a vital vote of confidence in the veterinary workforce."
To read the full submission, visit https://www.rcvs.org.uk/document-library/joint-rcvs-and-bva-submission-to-migration-advisory-committee/
'FLUTD and Dysuria – a frustration for many and not just the cat' will be presented by Dr Hanne Friis Lund (DVM) from Idexx and Katy Smith from Royal Canin (pictured right).
Hanne will be talking about diagnostics, focusing on urine analysis and laboratory tests, whilst Katy will discuss nutritional management of the condition.
Hanne said: "Feline lower urinary tract disease is a very common condition in both male and female cats affecting 1-3% of cats every year.
"It goes without saying that FLUTD causes great discomfort and pain for the feline, which is why the webinar will explore how best to manage the condition from a nutritional point of view.
"From the innovative Haematuria Detection by Blücare litter granules which turn blue when a urinary condition is detected to the new urinary range kibble from Royal Canin’s Veterinary Health Nutrition, the webinar will be leaving no stone unturned."
To register for the webinar, go to: https://vetportal.royalcanin.co.uk/cpd/webinar/
Mr Samuel had been removed from the Register in 2018 for causing unnecessary harm to numerous animals.
After being tried and convicted of several animal welfare offences alongside his former partner at Leeds Magistrates Court, Mr Samuel was sentenced to 12 weeks’ imprisonment, suspended for 12-months on the condition that he did 150 hours of unpaid work.
He was also ordered to pay a £100 fine and subjected to a disqualification order under the Animal Welfare Act for three years.
Mr Samuel’s application for restoration was based on the facts that he accepted the seriousness of his actions and that he did not challenge the DC’s 2018 decision.
The Committee also heard evidence that since his removal from the Register, Mr Samuel - who had run a first opinion veterinary practice for nine years prior to being struck off - has undertaken 340 hours of work experience with other veterinary surgeons and 20 hours of CPD.
Dr Samuel was represented by Counsel who outlined in his submissions to the Committee how Dr Samuel’s former partner had sole responsibility for the animals and that she was involved in rehoming dogs and cats and that their relationship was ‘stressful’, that this made Dr Samuel neglect his professional obligations, and that Dr Samuel was now in a different relationship and his life had been ‘transformed’ since his conviction.
The College opposed Dr Samuel being restored to the Register.
Ms Curtis, Counsel on behalf of the College, submitted to the Committee that Dr Samuel continued to represent a risk to the welfare of animals and that to allow him to be restored to the Register would undermine public confidence in the profession.
She explained that even though his sentence and Animal Welfare Act Disqualification Order had come to an end, and he was now legally able to own animals, this should not be equated with him now being fit to return to the Register.
Dr Austin Kirwan MRCVS, chairing the Committee, and speaking on its behalf, said: “Where a veterinary surgeon has shown himself to be capable of such indifference to the welfare of multiple animals, there remained, in the Committee’s view, a real risk of that indifference manifesting itself again.
"A registered veterinary surgeon is entrusted with the care of animals, often when they are at their most vulnerable, and sometimes for prolonged periods of time.
"Given the nature of the animal welfare offences committed by Dr Samuel, the Committee considered there would be a real and significant risk to animals if the high level of responsibility and trust that comes with registration were returned to him.
“For a veterinary surgeon, conduct involving neglect of animals is at the highest end of the spectrum of serious professional misconduct.
"For the reasons outlined above, the Committee considered Dr Samuel continued to represent a risk to animal welfare and thus allowing him to be restored to the Register would seriously undermine public confidence in the profession.
"For all these reasons the application to restore Dr Samuel to the Register is refused.”
The Committee’s full findings can be viewed at www.rcvs.org.uk/disciplinary
Dr Kalisz faced a total of nine charges (including 41 sub-charges).
The first was that in July 2020, she failed to carry out a clinical examination of the dog, failed to adequately interpret test results, failed to ask for help interpreting the results, and undertook an emergency Caesarean section without sufficient need to do so.
The other charges related to undertaking a colotomy without sufficient justification and without exercising sufficient clinical judgment throughout the procedure.
For both the Caesarean section and the colotomy, Dr Kalisz faced charges that she failed to obtain informed consent from the owners and failed to inform them that the colotomy had been carried out, or of the potential risks of the procedure, and also failed to provide enough information about aftercare.
It was also alleged that Dr Kalisz had demonstrated continual lapses in professional judgement, including failing to appropriately manage the spaniel’s worsening condition when it was presented to the practice again later, and that the clinical records in relation to the surgery were dishonest and/or misleading.
Dr Kalisz admitted serious professional misconduct, admitting to 29 of the sub-charges, while the remaining 12 sub-charges were denied.
The Committee found 30 of the sub-charges proven, with the remaining 11 not proven.
The Committee the considered aggravating factors, including the fact that Dr Kalisz's conduct led to the spaniel’s death, the colotomy was reckless and Dr Kalisz did not take steps to inform anybody or make a clinical record for the colotomy.
In mitigation, the Committee considered the fact that it was single and isolated incident (albeit one that spanned a number of days), that no other members of the clinical team involved raised concerns during the procedure, and the effect Covid had upon the veterinary profession.
The Committee found that of those charges proven, the ones relating to performing the colotomy, failing to manage the spaniel’s subsequent care and failing to mention the colotomy amounted to serious professional misconduct.
On deciding the sanction, the Committee took into account the mitigation submitted on behalf of Dr Kalisz and the written testimonials produced including the fact that she was young and inexperienced, had admitted her failings at an early stage, had made subsequent efforts to avoid a repetition of such behaviour and that a significant amount of time had passed since the incident.
The Committee also considered that Dr Kalisz had shown an exemplary level of insight, showing remorse for her actions, undertaking substantial continuing professional development, and finding appropriate ongoing professional mentorship.
The Committee was impressed by the character testimonials from veterinary co-workers, both current and at the time of these events, as well as from clients.
It was, the Committee said, apparent from those testimonials that Dr Kalisz had been open and honest with them about the charges and was considered to be an excellent, committed veterinary surgeon.
Paul Morris, chairing the Committee and speaking on its behalf said: “The Committee found that this was a single isolated incident, which involved serious lapses of clinical judgement.
"It was therefore concluded that, despite Dr Kalisz’s actions being reckless, the extensive mitigation and the high level of insight, coupled with steps taken to avoid repetition, meant that there was negligible future risk to animal welfare.
“The Committee did not consider it necessary to issue a warning to Dr Kalisz about her future conduct, on the basis that the Committee has concluded that there is little risk of repetition, so considered that a reprimand would be an appropriate sanction in this case.”
https://www.rcvs.org.uk/concerns/disciplinary-hearings
Ceva Animal Health has announced the launch of Vectra Felis, a new spot-on flea treatment for cats.
The new product contains two active ingredients: dinotefuran and pyriproxyfen. The first is an adulticide which Ceva says kills fleas on contact, thereby stopping fleas biting before they die. The second ingredient is an Insect Growth Regulator (IGR) which prevents flea reproduction and adult flea emergence, so protecting the cat and its environment from future flea attacks.
According to the company, Vectra Felis ensures that over 95% of fleas are killed within two hours and the effects last for a month.
In addition, Ceva highlights the product's patented applicator, which has an elongated smooth tip for quick and easy application. The company says it also provides accurate dosing and facilitates clean administration as nothing comes out until the tube is squeezed. Kittens can be treated from seven weeks of age (weighing at least 0.6kg).
For further information on Vectra Felis, contact your local Ceva territory manager or call 01494 781510.
People are invited to organise or join a walk to raise money for Canine Arthritis Management and its work to educate both dog owners and veterinary professionals about how even the smallest of changes can help to enhance the life of a dog with arthritis.
CAM highlights recent work from the Royal Veterinary College and University of Sydney through VetCompass, which highlighted some of the biggest welfare challenges facing our pet population including obesity, dental disease and osteoarthritis, with osteoarthritis identified as one of the most severe conditions.
Hannah said: "We need to start more conversations about arthritis; both dog owners and vets need to be more aware of the steps we can take to help prevent arthritis, and where dogs are affected, how we can take positive action to help them live fulfilled and comfortable lives."
Hannah says that arthritis is currently one of the biggest causes of owners choosing to euthanise their dogs, and she hopes that owners taking part in the walks will help spread the word that arthritis can be managed.
To find out more about the Big September Walks visit www.facebook.com/CAMBigSeptemberWalks
Fergus Allerton has become the Editor-in-Chief for Part A: Canine and Feline, whilst Joanna Hedley is the Editor-in-Chief for Part B: Exotic Pets.
For both formularies, the editorial panels have reviewed the drug monographs to make sure all the information is up to date.
Part A includes:
Part B includes:
BSAVA President, Sue Paterson said: "The BSAVA Small Animal Formulary is recognised as an invaluable asset for the small animal clinician and is one of the Association’s most useful member benefits. Busy small animal clinicians in both primary care and referral practice will find this evidence-based resource an invaluable help with immediate prescribing advice."
Eligible BSAVA members will receive a complimentary print copy of Part A: Canine and Feline, and those who renew their membership in 2020 will also receive Part B: Exotic Pets as a loyalty reward gift.
Both Part A and Part B are available:
For more information, visit: https://www.bsava.com.
Rachel has also qualified as a member of the dentistry chapter of the Australian and New Zealand College of Veterinary Scientists, and regularly tends to the oral health of zoo and sanctuary animals, including bears, cheetahs, tigers and snow leopards.
She said: "I’m excited to be joining North Downs, which is renowned as a centre of excellence for specialist veterinary care, and I’m really looking forward to this new role. There is a clear benefit in having a multidisciplinary team on site to approach oral surgery cases.
"Dentistry is such a rewarding area and can deliver immediate changes to our patients’ health and well-being.
"Many dental diseases can also be prevented, so I am committed to educating owners about their pets’ oral health and also veterinary surgeons and nurses, about new techniques, best practice, materials and equipment."
North Downs hospital director Terry Emmerson said: "Our aim is always to provide first-class care for our patients and to give an excellent service to their owners and the vets who refer cases to us.
"Rachel’s new dentistry service will be yet another specialist discipline on offer at North Downs to further extend the excellent care and treatment we offer here."
The appointment means that North Downs has a total of 11 specialist services, and makes it one of only a handful of centres in the UK that offer a dentistry service run by a dentistry specialist.
Jonathan Hill (UK Country Manager) said: “I’m delighted to announce that TVM UK is changing its name to Dômes Pharma.
"This will align with the other operating companies within the group.
"TVM UK has always been owned by the Dômes Pharma group, and since the start of our journey in the UK market we have been synonymous with expertise and outstanding levels of customer service in selected speciality segments of the animal health market and this won’t change.”
“Under the Dômes Pharma name we will continue to build and grow on this very strong foundation.
"I’m looking forward to working with the entire Dômes Pharma team as we increase our presence as a leading specialty pharmaceutical company, bringing our ethos to new speciality segments with innovative products and solutions for vets in the UK.
"Dômes Pharma remains a family-owned business, and the culture of the company really reflects this and we live by our values of kindness, boldness and responsibility.” https://www.domespharma.com https://www.tvm-uk.com
The BVA Board oversees the performance of the Association and is responsible for corporate and financial governance and for setting the BVA’s strategic direction. It consists of nine members: the three Officers of the BVA, four Directors appointed by BVA Council and up to 2 non-veterinary Directors appointed by the Board. The Chairman is elected by the Board.
Philip, a Bristol University Veterinary School graduate, spent seven years in mixed practice in Sussex, Kent and Suffolk before embarking on a career in the veterinary pharmaceutical industry.
He became CEO of Novartis Animal Health UK Ltd in 1996 (where, incidentally, he was ultimately responsible for signing up a wet-behind-the-ears PR consultant by the name of Arlo Guthrie and giving the go-ahead for the development of vetnurse.co.uk, which in turn led to the launch of vetsurgeon.org). In 2003 he became the company's Head of Global Marketing, and in 2005, Head of Global Business Development.
Philip has also run business elective training at the Royal Veterinary College, which has provided first-hand experience of the concerns and opportunities facing new graduates within a changing profession.
Gudrun Ravetz, President of the British Veterinary Association, said: "We are delighted to announce Philip Lowndes as the new Chairman of the BVA Board. His experience and expertise in business, knowledge of the veterinary profession and involvement with BVA will be of great value as we continue to grow our membership and expand our services and support for vets, especially during the uncertainty caused by Brexit."
Philip holds previous chair experience, as Chairman of the National Office of Animal Health (NOAH) between 1997-2004, and currently sits as Chairman of both the Novartis UK Pension Trustee Board and its Investment Committee. He joined BVA’s Board in 2013 and was re-elected by BVA Council for a second term in 2016. He will be taking over from Derek Williams, who stepped down in March after seven years of tireless work as Chairman.
Gudrun said: "I also want to take this opportunity to thank Derek Williams for all the hard work he has put in over many years. In his role as Chairman Derek’s experience and expertise have been vital in helping BVA grow as an organisation."
Philip said: "I am honoured to be elected as the next Chairman of the BVA and look forward to chairing the Board as it addresses the challenges ahead. The veterinary profession needs and deserves vibrant representation and it is the Board’s role to ensure that the organisation has the ability and the resources to achieve this to the benefit of our membership."
The BVA Board also gained a new non-veterinary Board Director, Steven Anderson Dixon, from April. Mr Dixon brings with him a successful career in newspaper and magazine publishing, which will be an asset as BVA consolidates and continues to develop its portfolio of veterinary journals.
The Essity Veterinary Academy covers four topics of education: Anatomy and Physiology of Wound Healing, Infection Management, Exudate Management and a Wound Assessment Workshop.
Richard Barker, Account Sales Executive said: "Essity Veterinary Academy events allow us to educate veterinary professionals with a full, comprehensive day of wound management.
"We have run our Academy events for the last two years and the feedback we have had has always been positive, therefore the decision to run four events again this year was an easy one.
"The events offer a great opportunity to share best practice with other veterinary professionals, and to obtain invaluable information from our Medical Education Manager, who has vast experience in dealing with all areas of wound management. We are very lucky to be able to offer these events free of charge and we can’t wait for the first event to begin on 18th June."
Essity is hosting these events across four venues, with the days running from 09:00 – 16:00, refreshments and lunch provided. The venues available this year are:
18th June, Huntingdon Racecourse
9th July, West Midlands Safari Park
17th September, Durham Cricket Club (Emirates Stadium)
24th September, Edinburgh Zoo
To book your place, email animalhealthcare@essity.com, giving your name, job title, practice details, telephone number and any dietary requirements.
Alternatively, if you would like further information please dial 01482 670124.
The expansion has increased the hospital's footprint by 30%, adding three new operating theatres, six new consult rooms and new feline facilities, including a cat-only waiting room, consult room and treatment area.
Hospital owner, IVC Evidensia said the expansion has been driven in part by the pet ownership boom of the last few years and increased demand for the hospital’s services.
To meet the demand, Vale has expanded its office space, adding desk space for a further 25 vets.
There are also new ultrasound and cardiology rooms, a new dental suite and enlarged prep and recovery areas.
The existing kennel area has doubled in size with the addition of nine new walk-in kennels, a bespoke isolation ward and secure outdoor runs.
Richard Artingstall, clinical director at Vale Referrals, said: “We’ve been working on this expansion for a long time and it’s incredible to see it complete.
"Our new and improved facilities mean we can give even more pets across the Southwest the gold standard treatment that they deserve and support our colleagues from neighbouring vet practices with extensive referral services.
"The feedback from pets and owners so far has been very rewarding to hear.”
The feedback from pets?
Really?
VetSurgeon.org contacted recent patient Dougal McDoggins for comment.
He said: "Woof."
www.valereferrals.co.uk.
Despite the fact that homeopathic preparations are supposed to be diluted to the point where none of the original ingredient remains, the FDA says it has received increasing reports of products containing distinctly unhomeopathic quantities of things like belladonna being associated with serious adverse events.
The FDA has also had to issue warnings about homeopathic zinc-containing intranasal products which may cause a loss of the sense of smell and other homeopathic remedies which contain potentially toxic ingredients, such as nux vomica, which contains strychnine.
However, it is not just products with safety concerns that the new proposals are designed to address. Following in the footsteps of the NHS, the Australian National Health and Medical Research Council, The House of Commons Science and Technology Committee and more recently, the Royal College of Veterinary Surgeons and the European Academies Science Advisory Council (EASAC), the new FDA proposals highlight the risk from homeopathic remedies being marketed for serious diseases or conditions when they have not been shown to offer clinical benefits.
The proposals also highlight the risk to vulnerable populations that: "may also be at greater risk of harm as a result of foregoing the use of medical treatments that have been found safe and effective."
FDA Commissioner Scott Gottlieb, M.D. said: "In recent years, we’ve seen a large uptick in products labeled as homeopathic that are being marketed for a wide array of diseases and conditions, from the common cold to cancer.
"In many cases, people may be placing their trust and money in therapies that may bring little to no benefit in combating serious ailments, or worse – that may cause significant and even irreparable harm because the products are poorly manufactured, or contain active ingredients that aren’t adequately tested or disclosed to patients.
"Our approach to regulating homeopathic drugs must evolve to reflect the current complexity of the market, by taking a more risk-based approach to enforcement. We respect that some individuals want to use alternative treatments, but the FDA has a responsibility to protect the public from products that may not deliver any benefit and have the potential to cause harm."
VetSurgeon.org supports the Campaign for Rational Veterinary Medicine.
Photo: Multicolored homeopathy tubes isolated on a white background. Lush. Shutterstock.
Animalcare's new Cephacare flavour antibiotic has received a response of 'good' or 'very good' in 80% of cases in a recent field study of superficial pyoderma in dogs. When asked to rate the effectiveness of the cephalexin-based antibiotic, more than half of the cases were awarded the highest response level of 'very good'.
Animalcare asked vets from across the country to participate in the study in order to confirm the company's own opinion. Each vet recorded five cases of superficial pyoderma in dogs and scored the effectiveness of treating the condition with Cephacare flavour. The first vets to complete their assessment forms received a free copy of the BSAVA Manual of Small Animal Dermatology worth £85.
The antibiotic proved effective across 19 different breeds, with animal weights ranging from 7kg to 70kg. Varying degrees of condition severity from mild through to severe were recorded with the average treatment length being 14-17 days. A number of 'severe' cases were treated with positive results. Severe was defined as long standing or recurrent areas of papules, crusting papules, epidermal collarettes and intact pustules.
Tony Liepman, Animalcare Market Manager, said: "A study like this confirms the product's effectiveness and, importantly, the acceptance of Cephacare flavour in real-world cases."
Virbac has launched Deltanil, a deltamethrin-based pour-on solution indicated in dairy and beef cattle for use against flies and lice with a zero milk withdrawal period. It is also effective in sheep against ticks, lice, keds and blowfly strike and against lice and ticks in lambs.
Deltanil is presented for use with the company's Farmpack and Flexibag dispensing system, which was awarded the 2014 PharmaPack Award for Innovative Packaging. Virbac says the system offers farmers a convenient approach to treatment, combining easy application with freedom of movement and the flexibility of a long stability period once the product is opened.
The Farmpack backpack holds a 2.5 litre Flexibag of Deltanil solution, sufficient for the treatment of 250 cattle.
The Flexibag is a flexible, multi-layered, multi-component bag designed to protect and preserve medication, giving Deltanil a two year proven stability period after opening. Unopened, Deltanil has a three year shelf life.
Virbac Product Manager for Large Animals Brigitte Goasduf MRCVS said: "External parasites are a year-round threat to dairy and beef herds and can have a significant economic impact on yields. With the launch of Deltanil, we are offering a new approach to product application, one which is ideally suited to the practical conditions on farm and which addresses the challenges often faced in using pour ons.
"We believe that Deltanil, with its zero milk withdrawal period for dairy cattle and sheep and innovative Farmpack and Flexibag dispensing system, sets a new standard for products of this type.
"Deltanil is based on deltamethrin, a tried and trusted parasiticide. It offers a convenient approach to administration with a 10ml dosage per cow, irrespective of weight, and is presented in two sizes - the 2.5 litre Flexibag and a 1litre dispensing bottle. The 1litre bottle offers a year's stability once opened. The dosage per sheep is 5ml, irrespective of weight, with a 2.5ml dosage for lambs."
A new equine parasite supplement to the online peer-reviewed publication Parasites and Vectors has been published by Fort Dodge.
Entitled "Equine parasites: diagnosis and control - a current perspective," it contains papers on a range of topics including a major European resistance study into key anthelmintic molecules. It is authored by equine parasitology experts and opinion leaders from around the world and was first published in September 2009. It is freely available at http://www.parasitesandvectors.com/
The charity, which helps around 200,000 cats and kittens in the UK each year needs someone with animal welfare skills to join its team of nine trustees who are responsible for the charity’s strategy, policy and oversight.
The ideal candidate will have a degree in veterinary medicine, animal behaviour or an equivalent qualification, together with an understanding of the voluntary sector and management experience gained at a large national organisation, university or veterinary practice.
Sue Field, Cats Protection’s Director of Volunteering, said: "This is an exciting role which focuses on further improving cat welfare, whether that be cats in Cats Protection’s care or the services that we offer to cat owners to help them better care for their pet.
"We deliver our work through over 10,000 volunteers and staff so we’re hoping to attract a strong team player who would enjoy the challenge of shaping strategy and policy across our large and multi-faceted organisation.
"In return we can offer the opportunity to develop new and existing skills at trustee level plus the opportunity to make a real difference to the welfare of cats and kittens. If this sounds like a challenge you’d relish, then we’d love to hear from you."
To apply for the role, visit https://www.cats.org.uk/get-involved/volunteering/find-an-opportunity?id=3954.
If you would like an informal chat about the role, contact Clare Radlett on 01825 741211 or email: claire.radlett@cats.org.uk
The closing date for applications is 5pm on Monday 19th February 2018.
The company says the new range performs as well as the leading brands and delivers consistently reliable sterilisation, but at a much lower price point than the market has seen before. The entry level 8 Litre machine retails at £1,100.
The Yeson machines range in size from an 8 litre to a 22 litre capacity and offer quiet Class B operation, 7 pre-set sterilisation programs, B&D Helix testing and a choice of printer or USB reporting.
Yeson UK MD Will Thomas said: "The autoclave market has been dominated by a few major players for many years and until now they’ve been largely unchallenged. Many people are now asking “why should I pay thousands more for a utility machine such as an autoclave? We’re just hoping that we can meet the demand."
For more information, visit www.yeson-uk.com
The researchers say that research thus far has focused on developing treatments to manage idiopathic epilepsy and little attention has been given to the emotional and logistical challenges for owners managing their dog’s condition.
This study used semi-structured interviews to explore how owners’ lives were changed following their dogs’ diagnosis and glean in-depth insights into their lives.
The research discovered that following their dog’s initial seizure, all interviewees recalled feeling negative emotions such as being distraught, fearful or uncertain regarding their dog’s future and disease progression. Prior experience with canine epilepsy was rare, and owners were shocked and distressed by the appearance of their dog’s seizures.
Whilst many owners discussed a very emotionally close dog-owner bond, owning a dog with epilepsy had a significant impact on their lifestyle. Impacts affected many aspects of daily routines, and in some cases, owners’ jobs. The unpredictable and sometimes inconvenient timing of seizures negatively impacted owners’ sleep and wellbeing. This unpredictability also made some owners feel that they were living with “a ticking time bomb”.
Other limitations included strict daily medication schedules and difficulty finding assistance in caring for their dog. This, combined with a fear of leaving their dog unsupervised, had social implications in some instances and led to increased use of the Internet and online groups for peer support. Owners also reported that friends, family and colleagues did not always understand the magnitude of commitment required.
Amy Pergande, Small Animal Intern at the RVC and primary author of the study, said: "We are sincerely grateful to the owners who participated in this study for providing us with such detailed and often emotive accounts of their experiences. Many of the participants had willingly altered many aspects of their daily routine for their dogs, both socially and professionally, and sometimes at the expense of their own quality of life."
This research highlights that further consideration of these factors by veterinary professionals and the friends and families of owners of these dogs could improve owner quality of life and facilitate the provision of additional, much needed support.
Rowena Packer, Lecturer in Companion Animal Behaviour and Welfare Science and research lead in canine epilepsy at the RVC, said: "Epilepsy can be an extremely tough condition for owners to manage, where the love, time and money owners dedicate to their dogs is not necessarily matched by a significant improvement in their condition, with seizures often continuing unabated. Our study has revealed previously unrecognised or under-appreciated impacts that epilepsy introduced to these owners’ lives. Improved awareness and understanding of these challenges by veterinary professionals have the potential to improve communication with clients, to avoid owners feeling that social media is the only place they can go to feel supported and understood”.
These findings increase the understanding of the sometimes negative and often profound emotional effects and lifestyle changes experienced by owners managing a dog with idiopathic epilepsy. With better support and resources, the reported impacts could potentially be minimised to protect owner quality of life.
Zoe Belshaw, independent research collaborator, said: “The welfare of pets and their owners can be closely intertwined. This research exploring how owners’ lives change when their dogs develop epilepsy is another important piece in the jigsaw of understanding both what the veterinary profession can do to best support our clients, but also in starting to appreciate the substantial wider societal impacts of chronic ill health in our nations’ pets”.
The full paper is open access and available at: https://bmcvetres.biomedcentral.com/articles/10.1186/s12917-020-02669-w
Reference
Photo: The Melias Studio
Novartis Animal Health has announced the launch of a campaign to improve awareness of and improve education about atopic dermatitis (AD), to coincide with the 10th anniversary of Atopica.
As part of the campaign, the company is inviting veterinary surgeons to take part in an online survey for the chance to win an iPad mini: www.surveymonkey.com/s/atopica
In addition, Novartis says it will be offering all sorts of new educational materials for both vets and owners, including research into current trends and attitudes towards AD, insights from experts in the field, and case studies.
Ricardo Garvao, Category Manager for Atopica said: "This year marks an important milestone for the Atopica brand that wouldn't have been possible without the backing of so many vets. Continued investment by Novartis Animal Health into research and education seems a fitting way to extend thanks for this support and so forms one of the key elements of the 'Decade of Comfort' campaign. I am constantly amazed at just how dedicated and hard-working vets are and am immensely proud that Novartis Animal Health shares their goal to help pets remain happy and healthy."